1. Michael C. Byrns and Trevor M. Penning. Environmental toxicology: carcinogens and heavy metals. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1876.
2. Gerald G. Briggs and Roger K. Freeman. D. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 1056-1057.
3. Novartis Pharmaceuticals. A Study Assessing the Efficacy and Safety of Deferasirox in Patients with Transfusion-dependent Iron Overload. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on February 2020] [Accessed 28th November 2020] https://clinicaltrials.gov/ct2/show/NCT00171821
4. Novartis Pharmaceuticals. Efficacy and Safety Study of Deferasirox in Patients with Non-transfusion Dependent Thalassemia (THETIS). NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on October 2019] [Accessed 28th November 2020] https://www.clinicaltrials.gov/ct2/show/NCT01709838
5. Ali Taher, Amal El-Beshlawy, Mohsen S Elalfy, Kusai Al Zir, Shahina Daar, Dany Habr, Ulrike Kriemler-Krahn, Abdel Hmissi and Abdullah Al Jefri. Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study. NCBI; PMC US National Library of Medicine, National Institute of Health. June 2009. [Accessed 28th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730551/
6. Taj Pharma India Ltd. DEFRATAJ 500MG, 250MG (DEFERASIROX). [Accessed 28th November 2020] https://defrataj.tajpharma.com/patient-information-leaflet-defrataj-film-coated-tablets.pdf
7. Ciplamed. DESIROX Tablets (Deferasirox). Ciplamed.com. [Revised on April 2020] [Accessed 28th November 2020] https://www.ciplamed.com/content/desirox-tablets
8. Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July 2019] [Accessed 28th November 2020] https://www.medicines.org.uk/emc/files/pil.4329.pdf
9. Novartis Pharma Stein AG. U.S. Food & Drug Administration; [Revised on April 2007] [Accessed 28th November 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021882s002lbl.pdf